Cargando…
The HIV-1 transmission bottleneck
It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widel...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364581/ https://www.ncbi.nlm.nih.gov/pubmed/28335782 http://dx.doi.org/10.1186/s12977-017-0343-8 |
_version_ | 1782517350000492544 |
---|---|
author | Kariuki, Samuel Mundia Selhorst, Philippe Ariën, Kevin K. Dorfman, Jeffrey R. |
author_facet | Kariuki, Samuel Mundia Selhorst, Philippe Ariën, Kevin K. Dorfman, Jeffrey R. |
author_sort | Kariuki, Samuel Mundia |
collection | PubMed |
description | It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widely accepted idea that transmission selects for viral characteristics that facilitate crossing the mucosal barrier of the recipient’s genital tract, although the specific selective forces or advantages are not completely defined. However, there are other steps along the way to becoming a founder virus at which selection may occur. These steps include the transition from the donor’s general circulation to the genital tract compartment, survival within the transmission fluid, and establishment of a nascent stable local infection in the recipient’s genital tract. Finally, there is the possibility that important narrowing events may also occur during establishment of systemic infection. This is suggested by the surprising observation that the number of founder viruses detected after transmission in intravenous drug users is also limited. Although some of these steps may be heavily selective, others may result mostly in a stochastic narrowing of the available founder pool. Collectively, they shape the initial infection in each recipient. |
format | Online Article Text |
id | pubmed-5364581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53645812017-03-24 The HIV-1 transmission bottleneck Kariuki, Samuel Mundia Selhorst, Philippe Ariën, Kevin K. Dorfman, Jeffrey R. Retrovirology Commentary It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widely accepted idea that transmission selects for viral characteristics that facilitate crossing the mucosal barrier of the recipient’s genital tract, although the specific selective forces or advantages are not completely defined. However, there are other steps along the way to becoming a founder virus at which selection may occur. These steps include the transition from the donor’s general circulation to the genital tract compartment, survival within the transmission fluid, and establishment of a nascent stable local infection in the recipient’s genital tract. Finally, there is the possibility that important narrowing events may also occur during establishment of systemic infection. This is suggested by the surprising observation that the number of founder viruses detected after transmission in intravenous drug users is also limited. Although some of these steps may be heavily selective, others may result mostly in a stochastic narrowing of the available founder pool. Collectively, they shape the initial infection in each recipient. BioMed Central 2017-03-23 /pmc/articles/PMC5364581/ /pubmed/28335782 http://dx.doi.org/10.1186/s12977-017-0343-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Kariuki, Samuel Mundia Selhorst, Philippe Ariën, Kevin K. Dorfman, Jeffrey R. The HIV-1 transmission bottleneck |
title | The HIV-1 transmission bottleneck |
title_full | The HIV-1 transmission bottleneck |
title_fullStr | The HIV-1 transmission bottleneck |
title_full_unstemmed | The HIV-1 transmission bottleneck |
title_short | The HIV-1 transmission bottleneck |
title_sort | hiv-1 transmission bottleneck |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364581/ https://www.ncbi.nlm.nih.gov/pubmed/28335782 http://dx.doi.org/10.1186/s12977-017-0343-8 |
work_keys_str_mv | AT kariukisamuelmundia thehiv1transmissionbottleneck AT selhorstphilippe thehiv1transmissionbottleneck AT arienkevink thehiv1transmissionbottleneck AT dorfmanjeffreyr thehiv1transmissionbottleneck AT kariukisamuelmundia hiv1transmissionbottleneck AT selhorstphilippe hiv1transmissionbottleneck AT arienkevink hiv1transmissionbottleneck AT dorfmanjeffreyr hiv1transmissionbottleneck |